title: Decreased sensitivity of 5-HT(1D) receptors in melancholic depression.
abstract: BACKGROUND
  Brain serotonin (5-HT) function is abnormal in major depression, but the involvement of different 5-HT receptor subtypes has been little studied. The availability of selective ligands now makes it possible to test the sensitivity of 5-HT(1D) receptors in patients with depression.
  
  
  OBJECTIVE
  The aim of the study was to use the 5-HT(1D) receptor agonist, zolmitriptan, to test the sensitivity of 5-HT(1D) receptors in patients with depression before and after treatment with selective serotonin reuptake inhibitors (SSRIs).
  
  
  METHODS
  We measured the growth hormone response to zolmitriptan (5 mg orally) in patients with major depression before and after SSRI treatment. A matched sample of healthy subjects acted as a control group.
  
  
  RESULTS
  The growth hormone response to zolmitriptan was blunted in patients with a melancholic depressive syndrome. SSRI treatment produced a marked reduction in zolmitriptan-induced growth hormone release.
  
  
  CONCLUSIONS
  Patients with melancholic depression have impaired sensitivity of the post-synaptic 5-HT(1D) receptors that mediate growth hormone release. The reduction in 5-HT(1D) receptor sensitivity following SSRI treatment is probably an adaptive response to increased levels of synaptic 5-HT.
authors.affiliation: University Department of Psychiatry, Oxford.
authors.forename: R
authors.initials: R
authors.lastname: Whale
authors.forename: E M
authors.initials: EM
authors.lastname: Clifford
authors.forename: Z
authors.initials: Z
authors.lastname: Bhagwagar
authors.forename: P J
authors.initials: PJ
authors.lastname: Cowen
mesh_terms: D000328:Adult; D003866:Depressive Disorder / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008875:Middle Aged; D023303:Oxazolidinones / Q000097:blood; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism*; D017366:Serotonin Receptor Agonists / Q000097:blood; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D014363:Tryptamines
chemical_list: D019382:Human Growth Hormone; D006854:Hydrocortisone; D023303:Oxazolidinones; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors; D014363:Tryptamines; C089750:zolmitriptan